Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
Haematologica|May 15, 2012
Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocolVirginie Gandemer, Sylvie Chevret, Arnaud Petit, et al.BMC Cancer|January 16, 2009
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 studyVirginie Gandemer, Marie-Francoise Auclerc, Yves Perel, et al.Haematologica|October 7, 2008
Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcomePaola Ballerini, Judith Landman-Parker, Jean Michel Cayuela, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 studyCaroline Oudot, Marie-Françoise Auclerc, Vincent Levy, et al.Blood|April 25, 2007
The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young childrenEmmanuelle Clappier, Wendy Cuccuini, Anna Kalota, et al.Blood|October 21, 2017
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemiaArnaud Petit, Amélie Trinquand, Sylvie Chevret, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trialFrédéric Millot, André Baruchel, Joelle Guilhot, et al.Hemasphere|November 22, 2021
Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French ExperienceAnne Sophie Alary, Carole Maute, Olivier Kosmider, et al.Blood|May 22, 2010
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remissionOlivier Nibourel, Olivier Kosmider, Meyling Cheok, et al.Cancer|December 28, 2016
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept studyPhilippe Rousselot, Stéphane Prost, Joelle Guilhot, et al.Pageof 11